Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Takehara, M; Murakami, M; Inobe, M; Tanaka, K; Chikuma, S; Saito, I; Kanegae, Y; Yasunami, Y; Nakano, M; Yamashita, K; Todo, S; Uede, T
   Long-term acceptance of allografts by in vivo gene transfer of regulatableadenovirus vector containing CTLA4IgG and loxP
   HUMAN GENE THERAPY
   
   M. Takehara et al., "Long-term acceptance of allografts by in vivo gene transfer of regulatableadenovirus vector containing CTLA4IgG and loxP", HUM GENE TH, 12(4), 2001, pp. 415-426
2. Schneider, BL; Peduto, G; Aebischer, P
   A self-immunomodulating myoblast cell line for erythropoietin delivery
   GENE THERAPY
   
   B.L. Schneider et al., "A self-immunomodulating myoblast cell line for erythropoietin delivery", GENE THER, 8(1), 2001, pp. 58-66
3. Abe, T; Yamaguchi, Y; Takino, H; Fujita, N; Yamauchi-Degawa, M; Ozaki, M; Yamakawa, K; Sera, Y; Sakamaki, H; Uotani, S; Kawasaki, E; Awata, T; Yamasaki, H; Eguchi, K
   CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody
   DIABETIC MEDICINE
   
   T. Abe et al., "CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody", DIABET MED, 18(9), 2001, pp. 726-731
4. Lee, YJ; Lo, FS; Shu, SG; Wang, CH; Huang, CY; Liu, HF; Wu, CC; Yang, TY; Chang, JG
   The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus
   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
   
   Y.J. Lee et al., "The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus", J PED END M, 14(4), 2001, pp. 383-388
5. Hizawa, N; Yamaguchi, E; Jinushi, E; Konno, S; Kawakami, Y; Nishimura, M
   Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B
   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
   
   N. Hizawa et al., "Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B", J ALLERG CL, 108(1), 2001, pp. 74-79
6. Rasmussen, HB; Kelly, MA; Francis, DA; Clausen, J
   CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese
   JOURNAL OF THE NEUROLOGICAL SCIENCES
   
   H.B. Rasmussen et al., "CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese", J NEUR SCI, 184(2), 2001, pp. 143-147
7. Merlo, A; Saverino, D; Tenca, C; Grossi, CE; Bruno, S; Ciccone, E
   CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4(+) T-cell clones specific for Mycobacterium tuberculosis
   INFECTION AND IMMUNITY
   
   A. Merlo et al., "CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4(+) T-cell clones specific for Mycobacterium tuberculosis", INFEC IMMUN, 69(10), 2001, pp. 6022-6029
8. Uchida, T; Kajiwara, K; Ideguchi, M; Yoshikawa, K; Morioka, J; Suzuki, M
   Co-administration of adenovirus vector expressing CTLA4-Ig prolongs transgene expression in the brain of mice sensitized with adenovirus
   BRAIN RESEARCH
   
   T. Uchida et al., "Co-administration of adenovirus vector expressing CTLA4-Ig prolongs transgene expression in the brain of mice sensitized with adenovirus", BRAIN RES, 898(2), 2001, pp. 272-280
9. Najafian, N; Sayegh, MH
   CTLA4-Ig: a novel immunosuppressive agent
   EXPERT OPINION ON INVESTIGATIONAL DRUGS
   
   N. Najafian e M.H. Sayegh, "CTLA4-Ig: a novel immunosuppressive agent", EXPERT OP I, 9(9), 2000, pp. 2147-2157
10. Chistyakov, DA; Savost'anov, KV; Turakulov, RI; Petunina, NA; Trukhina, LV; Kudinova, AV; Balabolkin, MI; Nosikov, VV
    Complex association analysis of Graves disease using a set of polymorphic markers
    MOLECULAR GENETICS AND METABOLISM
    
    D.A. Chistyakov et al., "Complex association analysis of Graves disease using a set of polymorphic markers", MOL GEN MET, 70(3), 2000, pp. 214-218
11. Tanaka, J; Mori, A; Ota, S; Yamamoto, Y; Kobayashi, S; Hashino, S; Asaka, M; Imamura, M
    Alterations in binding activity of T cell transcription factor CD28 responsive element binding complex (CD28RC) following allogeneic bone marrow transplantation
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    J. Tanaka et al., "Alterations in binding activity of T cell transcription factor CD28 responsive element binding complex (CD28RC) following allogeneic bone marrow transplantation", EUR J HAEMA, 64(5), 2000, pp. 333-339
12. Pal, N; Moon, JS; Sandhu, J; Domier, LL; D'Arcy, CJ
    Production of Barley yellow dwarf virus antisera by DNA immunization
    CANADIAN JOURNAL OF PLANT PATHOLOGY-REVUE CANADIENNE DE PHYTOPATHOLOGIE
    
    N. Pal et al., "Production of Barley yellow dwarf virus antisera by DNA immunization", CAN J PL P, 22(4), 2000, pp. 410-415
13. Ideguchi, M; Kajiwara, K; Yoshikawa, K; Uchida, T; Ito, H
    Local adenovirus-mediated CTLA4-immunoglobulin expression suppresses the immune responses to adenovirus vectors in the brain
    NEUROSCIENCE
    
    M. Ideguchi et al., "Local adenovirus-mediated CTLA4-immunoglobulin expression suppresses the immune responses to adenovirus vectors in the brain", NEUROSCIENC, 95(1), 2000, pp. 217-226
14. Kristiansen, OP; Nolsoe, RL; Holst, H; Reker, S; Larsen, ZM; Johannesen, J; Nerup, J; Pociot, F; Mandrup-Poulsen, T
    The intercellular adhesion molecule-1 K469E polymorphism in type 1 diabetes
    IMMUNOGENETICS
    
    O.P. Kristiansen et al., "The intercellular adhesion molecule-1 K469E polymorphism in type 1 diabetes", IMMUNOGENET, 52(1-2), 2000, pp. 107-111
15. Ensminger, SM; Witzke, O; Spriewald, BM; Morrison, K; Morris, PJ; Rose, ML; Wood, KJ
    CD8(+) T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade
    TRANSPLANTATION
    
    S.M. Ensminger et al., "CD8(+) T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade", TRANSPLANT, 69(12), 2000, pp. 2609-2612
16. Tezuka, K; Tsuji, T; Hirano, D; Tamatani, T; Sakamaki, K; Kobayashi, Y; Kamada, M
    Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    K. Tezuka et al., "Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family", BIOC BIOP R, 276(1), 2000, pp. 335-345
17. Naluai, AT; Nilsson, S; Samuelsson, L; Gudjonsdottir, AH; Ascher, H; Ek, J; Hallberg, B; Kristiansson, B; Martinsson, T; Nerman, O; Sollid, LM; Wahlstrom, J
    The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders
    TISSUE ANTIGENS
    
    A.T. Naluai et al., "The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders", TISSUE ANTI, 56(4), 2000, pp. 350-355
18. Chaikof, EL
    Engineering and material considerations in islet cell transplantation
    ANNUAL REVIEW OF BIOMEDICAL ENGINEERING
    
    E.L. Chaikof, "Engineering and material considerations in islet cell transplantation", ANN REV B E, 1, 1999, pp. 103-127
19. Nagaraju, K; Raben, N; Villalba, ML; Danning, C; Loeffler, LA; Lee, E; Tresser, N; Abati, A; Fetsch, P; Plotz, PH
    Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells
    CLINICAL IMMUNOLOGY
    
    K. Nagaraju et al., "Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells", CLIN IMMUNO, 92(2), 1999, pp. 161-169
20. Sato, J; Asakura, K; Murakami, M; Uede, T; Kataura, A
    Topical CTLA4-lg suppresses ongoing mucosal immune response in presensitized murine model of allergic rhinitis
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    
    J. Sato et al., "Topical CTLA4-lg suppresses ongoing mucosal immune response in presensitized murine model of allergic rhinitis", INT A AL IM, 119(3), 1999, pp. 197-204
21. Badenhoop, K; Donner, H; Pani, M; Rau, H; Siegmund, T; Braun, J
    Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a German population
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    K. Badenhoop et al., "Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a German population", EXP CL E D, 107, 1999, pp. S89-S92
22. Gebhardt, BM; Hodkin, M; Varnell, ED; Kaufman, HE
    Protection of corneal allografts by CTLA4-Ig
    CORNEA
    
    B.M. Gebhardt et al., "Protection of corneal allografts by CTLA4-Ig", CORNEA, 18(3), 1999, pp. 314-320
23. Otten, HG; Ossevoort, M; Vooijs, WC; van der Gouw, AP; de Boer, M; de Gast, GC
    Toward preclinical studies with anti-CD86 immunotoxin
    TRANSPLANTATION PROCEEDINGS
    
    H.G. Otten et al., "Toward preclinical studies with anti-CD86 immunotoxin", TRANSPLAN P, 31(1-2), 1999, pp. 1236-1236
24. Sato, J; Asakura, K; Murakami, M; Uede, T; Kataura, A
    Suppressive effects of CTLA4-IG on nasal allergic reactions in presensitized murine model
    LIFE SCIENCES
    
    J. Sato et al., "Suppressive effects of CTLA4-IG on nasal allergic reactions in presensitized murine model", LIFE SCI, 64(9), 1999, pp. 785-795
25. Buhlmann, JE; Gonzalez, M; Ginther, B; Panoskaltsis-Mortari, A; Blazar, BR; Greiner, DL; Rossini, AA; Flavell, R; Noelle, RJ
    Cutting edge: Sustained expansion of CD8(+) T cells requires CD154 expression by Th cells in acute graft versus host disease
    JOURNAL OF IMMUNOLOGY
    
    J.E. Buhlmann et al., "Cutting edge: Sustained expansion of CD8(+) T cells requires CD154 expression by Th cells in acute graft versus host disease", J IMMUNOL, 162(8), 1999, pp. 4373-4376
26. Fraser, JH; Rincon, M; McCoy, KD; Le Gros, G
    CTLA4 ligation attenuates AP-1, NFAT and NF-chi B activity in activated T cells
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    J.H. Fraser et al., "CTLA4 ligation attenuates AP-1, NFAT and NF-chi B activity in activated T cells", EUR J IMMUN, 29(3), 1999, pp. 838-844
27. Giannoukakis, N; Rudert, WA; Robbins, PD; Trucco, M
    Targeting autoimmune diabetes with gene therapy
    DIABETES
    
    N. Giannoukakis et al., "Targeting autoimmune diabetes with gene therapy", DIABETES, 48(11), 1999, pp. 2107-2121
28. Holopainen, P; Arvas, M; Sistonen, P; Mustalahti, K; Collin, P; Maki, M; Partanen, J
    CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study
    TISSUE ANTIGENS
    
    P. Holopainen et al., "CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study", TISSUE ANTI, 53(5), 1999, pp. 470-475
29. Gonzalez-Escribano, MF; Rodriguez, R; Valenzuela, A; Garcia, A; Garcia-Lozano, JR; Nunez-Roldan, A
    CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis
    TISSUE ANTIGENS
    
    M.F. Gonzalez-Escribano et al., "CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis", TISSUE ANTI, 53(3), 1999, pp. 296-300
30. Harbo, HF; Celius, EG; Vartdal, F; Spurkland, A
    CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis
    TISSUE ANTIGENS
    
    H.F. Harbo et al., "CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis", TISSUE ANTI, 53(1), 1999, pp. 106-110
31. SHE JX
    GENETIC-FACTORS IN TYPE-1 DIABETES - A COMPLEX DISEASE
    Journal of clinical ligand assay
    
    J.X. She, "GENETIC-FACTORS IN TYPE-1 DIABETES - A COMPLEX DISEASE", Journal of clinical ligand assay, 21(3), 1998, pp. 272-281
32. ANDERSON CC; SINCLAIR NRS
    FCR-MEDIATED INHIBITION OF CELL ACTIVATION AND OTHER FORMS OF COINHIBITION
    Critical reviews in immunology
    
    C.C. Anderson e N.R.S. Sinclair, "FCR-MEDIATED INHIBITION OF CELL ACTIVATION AND OTHER FORMS OF COINHIBITION", Critical reviews in immunology, 18(6), 1998, pp. 525-544
33. GREENFIELD EA; NGUYEN KA; KUCHROO VK
    CD28 B7 COSTIMULATION - A REVIEW
    Critical reviews in immunology
    
    E.A. Greenfield et al., "CD28 B7 COSTIMULATION - A REVIEW", Critical reviews in immunology, 18(5), 1998, pp. 389-418
34. KASAI M; KUMANO K; KURASAWA K; NAKAO A; SAITO Y; IWAMATO I
    BLOCKADE OF CD28 B7 INTERACTION SUPPRESSES ALLERGIC EOSINOPHILIC INFLAMMATION IN MICE/
    International archives of allergy and immunology
    
    M. Kasai et al., "BLOCKADE OF CD28 B7 INTERACTION SUPPRESSES ALLERGIC EOSINOPHILIC INFLAMMATION IN MICE/", International archives of allergy and immunology, 117, 1998, pp. 14-19
35. BABENSEE JE; ANDERSON JM; MCINTIRE LV; MIKOS AG
    HOST RESPONSE TO TISSUE ENGINEERED DEVICES
    Advanced drug delivery reviews
    
    J.E. Babensee et al., "HOST RESPONSE TO TISSUE ENGINEERED DEVICES", Advanced drug delivery reviews, 33(1-2), 1998, pp. 111-139
36. GUO Y; WU Y; KONG X; LIU Y
    IDENTIFICATION OF CONSERVED AMINO-ACIDS IN MURINE B7-1 IGV DOMAIN CRITICAL FOR CTLA4 CD28-B7 INTERACTION BY SITE-DIRECTED MUTAGENESIS - A NOVEL STRUCTURAL MODEL OF THE BINDING-SITE/
    Molecular immunology
    
    Y. Guo et al., "IDENTIFICATION OF CONSERVED AMINO-ACIDS IN MURINE B7-1 IGV DOMAIN CRITICAL FOR CTLA4 CD28-B7 INTERACTION BY SITE-DIRECTED MUTAGENESIS - A NOVEL STRUCTURAL MODEL OF THE BINDING-SITE/", Molecular immunology, 35(4), 1998, pp. 215-225
37. Croxford, JL; O'Neill, JK; Ali, RR; Browne, K; Byrnes, AP; Dallman, MJ; Wood, MJA; Feldmann, M; Baker, D
    Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    J.L. Croxford et al., "Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis", EUR J IMMUN, 28(12), 1998, pp. 3904-3916
38. OTTEN HG; VOOIJS WC; VANDERGOUW L; DEBOER M; DEGAST GC
    THE EFFECT OF IMMUNOTOXINS DIRECTED AGAINST CD80 AND CD86 ON PRIMARY T-CELL ALLORESPONSES
    Tissue antigens
    
    H.G. Otten et al., "THE EFFECT OF IMMUNOTOXINS DIRECTED AGAINST CD80 AND CD86 ON PRIMARY T-CELL ALLORESPONSES", Tissue antigens, 52(3), 1998, pp. 270-274
39. SEIDL C; DONNER H; FISCHER B; USADEL KH; SEIFRIED E; KALTWASSER JP; BADENHOOP K
    CTLA4 CODON-17 DIMORPHISM IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    Tissue antigens
    
    C. Seidl et al., "CTLA4 CODON-17 DIMORPHISM IN PATIENTS WITH RHEUMATOID-ARTHRITIS", Tissue antigens, 51(1), 1998, pp. 62-66
40. TRAN HM; NICKERSON PW; PATEL A; STROM TB; ALLEN RDM; OCONNELL PJ
    SHORT-TERM SUPPRESSION OF THE XENO-IMMUNE RESPONSE WITH MCTLA4-FC TREATMENT
    Xenotransplantation
    
    H.M. Tran et al., "SHORT-TERM SUPPRESSION OF THE XENO-IMMUNE RESPONSE WITH MCTLA4-FC TREATMENT", Xenotransplantation, 4(4), 1997, pp. 222-227
41. HOFFMAN LM; MAGUIRE AM; BENNETT J
    CELL-MEDIATED IMMUNE-RESPONSE AND STABILITY OF INTRAOCULAR TRANSGENE EXPRESSION AFTER ADENOVIRUS-MEDIATED DELIVERY
    Investigative ophthalmology & visual science
    
    L.M. Hoffman et al., "CELL-MEDIATED IMMUNE-RESPONSE AND STABILITY OF INTRAOCULAR TRANSGENE EXPRESSION AFTER ADENOVIRUS-MEDIATED DELIVERY", Investigative ophthalmology & visual science, 38(11), 1997, pp. 2224-2233
42. HALE DA; GOTTSCHALK R; MAKI T; MONACO AP
    USE OF CTLA-4IG IN COMBINATION WITH CONVENTIONAL IMMUNOSUPPRESSIVE AGENTS TO PROLONG ALLOGRAFT SURVIVAL
    Transplantation
    
    D.A. Hale et al., "USE OF CTLA-4IG IN COMBINATION WITH CONVENTIONAL IMMUNOSUPPRESSIVE AGENTS TO PROLONG ALLOGRAFT SURVIVAL", Transplantation, 64(6), 1997, pp. 897-900
43. XERRI L; DEVILARD E; HASSOUN J; OLIVE D; BIRG F
    IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS
    Journal of pathology
    
    L. Xerri et al., "IN-VIVO EXPRESSION OF THE CTLA4 INHIBITORY RECEPTOR IN MALIGNANT AND REACTIVE CELLS FROM HUMAN LYMPHOMAS", Journal of pathology, 183(2), 1997, pp. 182-187
44. SHARPE AH
    COSTIMULATORY SIGNALS AND VIRAL IMMUNITY
    Seminars in virology
    
    A.H. Sharpe, "COSTIMULATORY SIGNALS AND VIRAL IMMUNITY", Seminars in virology, 7(2), 1996, pp. 103-111
45. RESTIFO AC; IVISWOODWARD MA; TRAN HM; NICKERSON PW; LEHNERT AM; STROM TB; CHAPMAN JR; OCONNELL PJ
    THE POTENTIAL ROLE OF XENOGENEIC ANTIGEN-PRESENTING CELLS IN T-CELL CO-STIMULATION
    Xenotransplantation
    
    A.C. Restifo et al., "THE POTENTIAL ROLE OF XENOGENEIC ANTIGEN-PRESENTING CELLS IN T-CELL CO-STIMULATION", Xenotransplantation, 3(1), 1996, pp. 141-148
46. PERRIN PJ; SCOTT D; JUNE CH; RACKE MK
    B7-MEDIATED COSTIMULATION CAN EITHER PROVOKE OR PREVENT CLINICAL MANIFESTATIONS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
    Immunologic research
    
    P.J. Perrin et al., "B7-MEDIATED COSTIMULATION CAN EITHER PROVOKE OR PREVENT CLINICAL MANIFESTATIONS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS", Immunologic research, 14(3), 1995, pp. 189-199
47. VYTHDREESE FA; DELLEMIJN TAM; MAJOOR D; DEJONG D
    LOCALIZATION IN-SITU OF THE COSTIMULATORY MOLECULES B7.1, B7.2, CD40 AND THEIR LIGANDS IN NORMAL HUMAN LYMPHOID-TISSUE
    European Journal of Immunology
    
    F.A. Vythdreese et al., "LOCALIZATION IN-SITU OF THE COSTIMULATORY MOLECULES B7.1, B7.2, CD40 AND THEIR LIGANDS IN NORMAL HUMAN LYMPHOID-TISSUE", European Journal of Immunology, 25(11), 1995, pp. 3023-3029
48. MARZOWSKI J; WANG WC; FLESHER AR; RAFF HV
    FLUOROPHORE-LABELED CARBOHYDRATE ANALYSIS OF IMMUNOGLOBULIN FUSION PROTEINS - CORRELATION OF OLIGOSACCHARIDE CONTENT WITH IN-VIVO CLEARANCEPROFILE
    Biotechnology and bioengineering
    
    J. Marzowski et al., "FLUOROPHORE-LABELED CARBOHYDRATE ANALYSIS OF IMMUNOGLOBULIN FUSION PROTEINS - CORRELATION OF OLIGOSACCHARIDE CONTENT WITH IN-VIVO CLEARANCEPROFILE", Biotechnology and bioengineering, 46(5), 1995, pp. 399-407
49. KENNEDY MK; MOHLER KM; SHANEBECK KD; BAUM PR; PICHA KS; OTTENEVANS CA; JANEWAY CA; GRABSTEIN KH
    INDUCTION OF B-CELL COSTIMULATORY FUNCTION BY RECOMBINANT MURINE CD40LIGAND
    European Journal of Immunology
    
    M.K. Kennedy et al., "INDUCTION OF B-CELL COSTIMULATORY FUNCTION BY RECOMBINANT MURINE CD40LIGAND", European Journal of Immunology, 24(1), 1994, pp. 116-123